HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Single-Serve Vitamin Beverage Blends Target 'Pill-Fatigued' Consumers

Executive Summary

Tespo, VitaCup and Kannaway offer vitamin delivery options for the pill-wary with beverages infused with nutrients, many designed for single-serve coffee makers. Private equity investors help VitaCup expand its business while Kannaway new coffees and teas in Walmart in June.

You may also be interested in...



Nestle Personalized Nutrition Expands In Americas, Health Science Business Revenues Grow In Q1

Nestle expands its personalized nutrition offerings in the Americas with nesQino, featuring a digital app to make hot or cold beverages. It also reported consumer stockpiling boost its first-quarter Health Science sales. It continues to seek acquisitions, despite COVID-19 epidemic's drag on economic markets.

US Wellness Market In 2019: Amarin Wins, Loses On Supplements; Gottlieb Leaves With Consumer Health Flourish

Looking look back on US wellness market developments and events in 2019, HBW Insight finds a firm that doesn’t compete in the dietary supplement sector, Amarin, made a good bit of news that affected the industry during the year. We track news across the wellness space from the past year.

With TheraFlu PowerPods, GSK Brews Market For OTCs From Coffee Makers

GSK takes Theraflu brand from medicine cabinet to kitchen with launch of PowerPods of OTC ingredients delivered through single-serve coffee makers. Introduction of non-coffee pods also is growing, including lemonade, hot ciders, teas and Campbell's Soup pods.

Topics

UsernamePublicRestriction

Register

RS148803

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel